abstract |
The present invention discloses an antibody that binds to the human and Philippine monkey CEACAM5 protein, as well as an isolated nucleic acid, vector and host cell comprising a sequence encoding the antibody. In addition, the present invention discloses an immunoconjugate comprising the antibody conjugated or linked to a growth inhibitory agent and a pharmaceutical composition comprising the antibody or immunoconjugate of the present invention. The antibody or immunoconjugate of the present invention is used for the purpose of treatment or diagnosis of cancer. |